Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120131513 | 12013151 | 3 | F | 20010323 | 20160720 | 20160205 | 20160802 | EXP | US-BAYER-2016-022765 | BAYER | 44.00 | YR | A | F | Y | 81.18000 | KG | 20160802 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120131513 | 12013151 | 1 | PS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | Oral | 500 MG, UNK | 19537 | 500 | MG | TABLET | |||||||
| 120131513 | 12013151 | 2 | SS | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | 400 MG, UNK | 0 | 400 | MG | FILM-COATED TABLET | ||||||||
| 120131513 | 12013151 | 3 | SS | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | 400 MG, UNK | 0 | 400 | MG | FILM-COATED TABLET | ||||||||
| 120131513 | 12013151 | 4 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | 500 UNK, UNK | 0 | 500 | MG | |||||||||
| 120131513 | 12013151 | 5 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | 500 MG, UNK | 0 | 500 | MG | |||||||||
| 120131513 | 12013151 | 6 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | 500 MG, UNK | 0 | 500 | MG | MODIFIED-RELEASE FILM-COATED TABLET | ||||||||
| 120131513 | 12013151 | 7 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 20 MG, QD | 0 | 20 | MG | QD | ||||||||
| 120131513 | 12013151 | 8 | C | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | 0 | ||||||||||||
| 120131513 | 12013151 | 9 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | 10 MG, UNK | 0 | 10 | MG | QD | ||||||||
| 120131513 | 12013151 | 10 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 5000 | 0 | QD | ||||||||||
| 120131513 | 12013151 | 11 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120131513 | 12013151 | 7 | Cardiac disorder |
| 120131513 | 12013151 | 8 | Arthritis |
| 120131513 | 12013151 | 9 | Anxiety |
| 120131513 | 12013151 | 10 | Hypovitaminosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120131513 | 12013151 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120131513 | 12013151 | Anxiety | |
| 120131513 | 12013151 | Cardiovascular disorder | |
| 120131513 | 12013151 | Insomnia | |
| 120131513 | 12013151 | Mental disorder | |
| 120131513 | 12013151 | Musculoskeletal injury | |
| 120131513 | 12013151 | Nervous system disorder | |
| 120131513 | 12013151 | Neuropathy peripheral | |
| 120131513 | 12013151 | Pain | |
| 120131513 | 12013151 | Panic attack | |
| 120131513 | 12013151 | Skin injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120131513 | 12013151 | 1 | 20010323 | 20010415 | 0 | |
| 120131513 | 12013151 | 2 | 20060502 | 20060506 | 0 | |
| 120131513 | 12013151 | 3 | 20060609 | 20060613 | 0 | |
| 120131513 | 12013151 | 4 | 20060623 | 20060702 | 0 | |
| 120131513 | 12013151 | 5 | 20061006 | 20061012 | 0 | |
| 120131513 | 12013151 | 6 | 20080201 | 20080214 | 0 | |
| 120131513 | 12013151 | 11 | 2015 | 0 |